With an undergraduate student body of around 4,800, the Faculty’s School of Bioscience Education and the Guy’s King’s & St Thomas’ (GKT) School of Medical Education deliver a comprehensive biomedical education portfolio, including professional health programmes (Medicine, Nutrition & Dietetics, Pharmacy, Physiotherapy) and a wide range of BSc programmes in biomedical sciences. The Faculty also has 1,710 students registered on our ~40 Masters programmes covering basic science through to programmes for health and allied health professionals. Embedded in research groups in our Schools, there are 1,014 postgraduate clinical and non-clinical research (PhD/MDRes) students, approximately 25% of whom study part-time. Alongside these education programmes is our short course and continuing professional development provision which supports professionals to gain or refresh their skills and knowledge. Overall, the Faculty’s education programmes currently generate in the region of £70M per annum in tuition fee income, with additional UK Government annual core support of £18M for education.
The Faculty is in the process of setting up the first UK-partnered Medical School in China, in collaboration with the Southern University of Science & Technology (SUSTech). This is part of an ambitious project to establish a world-class Joint Education Institute in Shenzhen, China. The Joint School of Medicine plans to engage with the med-tech industry in southern China and Hong Kong to generate pedagogical and curriculum advances. In addition to Medicine, the Institute will deliver programmes in Biomedical Sciences and Biomedical Engineering, with plans to develop a wider portfolio of jointly delivered programmes.
The Faculty is recognised as having major strength in a wide range of research areas relevant to life sciences and medicine, from fundamental to applied research. There are several nationally awarded Research Centres hosted within the Faculty. Assisted by our close collaboration with clinical colleagues in the King’s Health Partner Trusts and the linked NIHR Biomedical Research Centre, and outstanding infrastructure, the Faculty’s research findings are able to impact directly on the clinical setting and on health outcomes for patients.
King’s Health Partners is an Academic Health Sciences Centre that has twenty-two thematic Clinical Academic Groups and five Institutes that bring together academics and clinicians who are committed to ensuring faster translation and adoption of research innovation into clinical practice. Having our academic staff based alongside their NHS counterparts further strengthens this dialogue between clinical and basic science, helping to accelerate the uptake of novel diagnostics, treatment and therapies.
The Faculty’s research excellence is reflected by the outcomes of REF2014, with 91.8% of the Faculty submission rated 4* (world leading) or 3* (internationally excellent). The breadth of the Faculty’s research is reflected by the fact it submitted returns to seven units of assessment including Clinical Medicine in which the Faculty ranked first in the UK in terms of the proportion of our overall submission that was ranked 4* or 3*. This work is only possible due to the wide range of funding that the Faculty attracts: it currently has an annual research grant income of about £100M from a range of research council, charitable funding sources and research contracts, with the UK Government’s core support for research being in the region of £27M per annum.
Both the Faculty’s research and education is built on a platform of partnerships across King’s College London, across London (including the Francis Crick Institute and London Advanced Therapies), nationally and internationally. In 2016, King’s College London became a founding academic partner alongside UCL and Imperial College in the Francis Crick Institute, London. In addition to joint academic appointments between King’s and the Crick, the partnership funds a vibrant PhD studentship programme and opportunities for mid-career academics to be seconded to the Crick for a fixed period. This research partnership has created productive collaborations, as demonstrated by the rapid response to the COVID-19 pandemic.